CT-179

DB17114InvestigationalSmall molecule

CT-179: Overview.

Mechanism: Pharmacologically active on Oligodendrocyte transcription factor 2
Curator reviewed
Formula / weight: C₁₇H₂₂Cl₂N₆O · 397.3 g/mol (avg)
Also known as: 1-(2-(3-(3,4-dichlorophenyl)ureido)-6-methyl-pyrimidin-4-yl)-amino-3(dimethylamino)propane · Urea, n-(3,4-dichlorophenyl)-n'-(4-((3-(dimethylamino)propyl)amino)-6-methyl-2-pyrimidinyl)-
Code names: CT-179

Resolves to

Compound

Structure

InChIKeyMWEZWAONAIZIAQ-UHFFFAOYSA-NSMILESCN(C)CCCNC1=NC(NC(=O)NC2=CC=C(Cl)C(Cl)=C2)=NC(C)=C1

Targets

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with CT-179, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.